ArticlePolymers2022
Investigating the Bond Strength of FRP Rebars in Concrete under High Temperature Using Gene-Expression Programming Model.
Article in Polymers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- An Experimental and FE Modeling Investigation of the Pull-Out Behavior of Anchoring Solutions in Concrete: A Comparative Study.Materials (Basel, Switzerland) · 2025Article
- Shear Mechanism of a Novel SFCBs-Reinforced Composite Shear Connector: Experimental, Theoretical Investigations and Numerical Model.Materials (Basel, Switzerland) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
In recent times, the use of fibre-reinforced plastic (FRP) has increased in reinforcing concrete structures. The bond strength of FRP rebars is one of the most significant parameters for characterising the overall efficacy of the concrete structures reinforced with FRP. However, in cases of elevated temperature, the bond of FRP-reinforced concrete can deteriorate depending on a number of factors, including the type of FRP bars used, its diameter, surface form, anchorage length, concrete strength, and cover thickness. Hence, accurate quantification of FRP rebars in concrete is of paramount importance, especially at high temperatures. In this study, an artificial intelligence (AI)-based genetic-expression programming (GEP) method was used to predict the bond strength of FRP rebars in concrete at high temperatures. In order to predict the bond strength, we used failure mode temperature, fibre type, bar surface, bar diameter, anchorage length, compressive strength, and cover-to-diameter ratio as input parameters. The experimental dataset of 146 tests at various elevated temperatures were established for training and validating the model. A total of 70% of the data was used for training the model and remaining 30% was used for validation. Various statistical indices such as correlation coefficient (R), the mean absolute error (MAE), and the root-mean-square error (RMSE) were used to assess the predictive veracity of the GEP model. After the trials, the optimum hyperparameters were 150, 8, and 4 as number of chromosomes, head size and number of genes, respectively. Different genetic factors, such as the number of chromosomes, the size of the head, and the number of genes, were evaluated in eleven separate trials. The results as obtained from the rigorous statistical analysis and parametric study show that the developed GEP model is robust and can predict the bond strength of FRP rebars in concrete under high temperature with reasonable accuracy (i.e., R, RMSE and MAE 0.941, 2.087, and 1.620, and 0.935, 2.370, and 2.046, respectively, for training and validation). More importantly, based on the FRP properties, the model has been translated into traceable mathematical formulation for easy calculations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.